Impact of Coronary Computed Tomographic Angiography Findings on the Medical Treatment and Control of Coronary Artery Disease and Its Risk Factors † † Conflicts of interest: Dr. Min has a research grant from GE Healthcare, Milwaukee, Wisconsin; is on the speaker's bureau for GE Healthcare; has a research grant from Vital Images, Minnetonka, Minnesota; and is a consultant for the Cordis Corporation, Miami Lakes, Florida. Dr. Devereux is a consultant for Merck & Company, Whitehouse Station, New Jersey; Novartis AG, Basel, Switzerland; Sanofi-Aventis, Paris, France; and Novo Nordisk A/S, Bagsværd, Denmark.
Titel:
Impact of Coronary Computed Tomographic Angiography Findings on the Medical Treatment and Control of Coronary Artery Disease and Its Risk Factors † † Conflicts of interest: Dr. Min has a research grant from GE Healthcare, Milwaukee, Wisconsin; is on the speaker's bureau for GE Healthcare; has a research grant from Vital Images, Minnetonka, Minnesota; and is a consultant for the Cordis Corporation, Miami Lakes, Florida. Dr. Devereux is a consultant for Merck & Company, Whitehouse Station, New Jersey; Novartis AG, Basel, Switzerland; Sanofi-Aventis, Paris, France; and Novo Nordisk A/S, Bagsværd, Denmark.
Auteur:
LaBounty, Troy M. Devereux, Richard B. Lin, Fay Y. Weinsaft, Jonathan W. Min, James K.